BMY: Analysis & Opinions

  1. Pipeline Setback at Bristol-Myers - Analyst Blog

    August 03, 2012
    Bristol-Myers Squibb Company (BMY) recently suffered a pipeline setback when it voluntarily decided to halt a phase ...
  2. Big Movers on the Healthcare Sector Today, Including BMY

    August 02, 2012
    It's been a bad day for the market after the morning's trading. The Nasdaq has fallen 0.4%; the S&P 500 has declined ...
  3. Portfolio Pruning 101

    July 27, 2012
    MoneyShow's Tom Aspray takes an in-depth look at his successful Charts in Play Portfolio, as he looks to take ...
  4. Generic Plavix & Avapro Hurt Sanofi - Analyst Blog

    July 27, 2012
    Sanofi (SNY) reported second quarter 2012 business earnings of 95 cents per American Depository Share (ADS), much ...
  5. Bristol-Myers Squibb's Second Quarter Earnings Report

    July 25, 2012
    Bristol-Myers Squibb Company (NYSE:BMY) announced its results for the second quarter on July 25, 2012. Bristol-Myers ...
  6. FDA Nod for Gilead's Truvada - Analyst Blog

    July 23, 2012
    The US Food and Drug Administration (FDA) recently approved Gilead Sciences, Inc.'s (GILD) once-daily oral Truvada ...
  7. Earnings Preview: Bristol-Myers - Analyst Blog

    July 23, 2012
    Biopharmaceutical giant  Bristol-Myers Squibb Company (BMY) is all set to unveil  its second quarter 2012 results ...
  8. Bristol-Myers Squibb Second Quarter Earnings Preview

    July 23, 2012
    Analysts are expecting a drop in profit for Bristol-Myers Squibb (NYSE:BMY) when it reports its results for the ...
  9. Dr. Reddy's Launches Generic Lipitor - Analyst Blog

    July 19, 2012
    Yet another generic version of Pfizer's (PFE) cholesterol drug, Lipitor (atorvastatin calcium), entered the market ...
  10. TPG to Acquire Par Pharma for $1.9B - Analyst Blog

    July 17, 2012
    Yet another acquisition agreement was recently announced in the pharma sector. US based specialty pharmaceutical ...
  11. Merck KGaA's Erbitux Disappoints - Analyst Blog

    July 10, 2012
    Merck KGaA (MKGAF) recently announced that Erbitux failed to achieve its primary endpoint in the phase III EXPAND ...
  12. FDA Approves Qiagen's KRAS Test - Analyst Blog

    July 09, 2012
    Molecular diagnostics solutions provider, Qiagen (QGEN) recently got the nod of the U.S. Food and Drug ...
  13. FDA Label Expansion for Erbitux - Analyst Blog

    July 09, 2012
    Bristol-Myers Squibb Company (BMY) and partner Eli Lilly & Company (LLY) recently announced that they have received ...
  14. Setback for Chelsea Therapeutics - Analyst Blog

    July 06, 2012
    Chelsea Therapeutics International, Ltd. (CHTP) recently suffered a setback when the US Food and Drug Administration ...
  15. GolinHarris Acquires Virgo Health - Analyst Blog

    July 06, 2012
    GolinHarris, a division of Interpublic Group (IPG) intends to acquire Virgo Heath, an independent UK-based ...
  16. Reddy Adds to Generic Portfolio - Analyst Blog

    July 05, 2012
    Dr. Reddy's Laboratories (RDY) recently announced the launch of its generic version of Roche's (RHHBY) Boniva ...
  17. Biggest Healthcare Sector Movers for July 3, 2012

    July 03, 2012
    The market is doing well so far today. The Nasdaq has moved up 0.7%; the S&P 500 is up 0.7%; and the Dow has risen ...
  18. Company News for July 3, 2012 - Corporate Summary

    July 03, 2012
    "    Speculations that founder Dick Schulze might turn Best Buy Co., Inc. (NYSE:BBY) into a private company helped ...
  19. Gilead Seeks FDA OK for Cobicistat - Analyst Blog

    July 02, 2012
    Recently, Gilead Sciences, Inc. (GILD) announced that it has filed a marketing application seeking approval for its ...
  20. Bristol-Myers to Buy Amylin - Analyst Blog

    July 02, 2012
    In a bid to diversify its business to combat the generic threat and bolster its position in the lucrative diabetes ...
Marketplace
Trading Center